Back to User profile » Dr Nan Luo
Paper published by Dr Nan Luo:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-Effectiveness Analysis Of EGFR Mutation Testing And Afatinib Versus Gemcitabine-Cisplatin As First-Line Therapy For Advanced Non-Small-Cell Lung Cancer In China
You R, Liu J, Wu DBC, Qian X, Lyu B, Zhang Y, Luo N
Cancer Management and Research 2019, 11:10239-10248
Published Date: 5 December 2019